{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:24:41Z","timestamp":1792250681912,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009015","name":"Abbott Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018145","name":"Zeon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004820","name":"Mochida Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015731","name":"Bayer Yakuhin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"Astrazeneca PLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030831","name":"Novartis Pharma K.K","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030831","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12928-025-01196-5","type":"journal-article","created":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T22:43:38Z","timestamp":1758494618000},"page":"163-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Influence of the initial expansion position of balloon-expandable valves on valve distortion in transcatheter aortic valve implantation"],"prefix":"10.1007","volume":"41","author":[{"given":"Yosuke","family":"Kirii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiyo","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tairo","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"1196_CR1","first-page":"524","volume":"75","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol Engl Ed. 2022;75:524.","journal-title":"Rev Esp Cardiol Engl Ed"},{"key":"1196_CR2","first-page":"e35","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e35\u201371.","journal-title":"Circulation"},{"key":"1196_CR3","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695\u2013705.","journal-title":"N Engl J Med"},{"key":"1196_CR4","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/eurheartj\/ehab375","volume":"42","author":"TH J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen TH, Thyregod HGH, Ihlemann N, Nissen H, Petursson P, Kjeldsen BJ, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021;42:2912\u20139.","journal-title":"Eur Heart J"},{"key":"1196_CR5","doi-asserted-by":"publisher","first-page":"20150737","DOI":"10.1098\/rsif.2015.0737","volume":"12","author":"PS Gunning","year":"2015","unstructured":"Gunning PS, Saikrishnan N, Yoganathan AP, McNamara LM. Total ellipse of the heart valve: the impact of eccentric stent distortion on the regional dynamic deformation of pericardial tissue leaflets of a transcatheter aortic valve replacement. J R Soc Interface. 2015;12:20150737.","journal-title":"J R Soc Interface"},{"key":"1196_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s10439-014-1008-6","volume":"42","author":"PS Gunning","year":"2014","unstructured":"Gunning PS, Saikrishnan N, McNamara LM, Yoganathan AP. An in vitro evaluation of the impact of eccentric deployment on transcatheter aortic valve hemodynamics. Ann Biomed Eng. 2014;42:1195\u2013206.","journal-title":"Ann Biomed Eng"},{"key":"1196_CR7","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1016\/j.jbiomech.2016.03.036","volume":"49","author":"F Sturla","year":"2016","unstructured":"Sturla F, Ronzoni M, Vitali M, Dimasi A, Vismara R, Preston-Maher G, et al. Impact of different aortic valve calcification patterns on the outcome of transcatheter aortic valve implantation: a finite element study. J Biomech. 2016;49:2520\u201330.","journal-title":"J Biomech"},{"key":"1196_CR8","doi-asserted-by":"publisher","first-page":"8829906","DOI":"10.1155\/2021\/8829906","volume":"2021","author":"A Nakajima","year":"2021","unstructured":"Nakajima A, Naganuma T, Yuki H, Onishi H, Amano T, Yabushita H, et al. The impact of aortic valvular calcium on transcatheter heart valve distortion. J Intervent Cardiol. 2021;2021:8829906.","journal-title":"J Intervent Cardiol"},{"key":"1196_CR9","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1253\/circj.CJ-20-0135","volume":"84","author":"C Izumi","year":"2020","unstructured":"Izumi C, Eishi K, Ashihara K, Arita T, Otsuji Y, Kunihara T, et al. JCS\/JSCS\/JATS\/JSVS 2020 Guidelines on the management of valvular heart disease. Circ J. 2020;84:2037\u2013119.","journal-title":"Circ J"},{"key":"1196_CR10","first-page":"37","volume":"19","author":"G Tarantini","year":"2023","unstructured":"Tarantini G, Tang G, Nai Fovino L, Blackman D, Van Mieghem NM, Kim W-K, et al. Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2023;19:37\u201352.","journal-title":"EuroIntervention J. Eur. Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol."},{"key":"1196_CR11","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","volume":"77","author":"P G\u00e9n\u00e9reux","year":"2021","unstructured":"G\u00e9n\u00e9reux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, et al. Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol. 2021;77:2717\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"1196_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jcmg.2017.05.007","volume":"10","author":"MJ Blaha","year":"2017","unstructured":"Blaha MJ, Mortensen MB, Kianoush S, Tota-Maharaj R, Cainzos-Achirica M. Coronary artery calcium scoring: is it time for a change in methodology? JACC Cardiovasc Imaging. 2017;10:923\u201337.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1196_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1196_CR14","doi-asserted-by":"crossref","unstructured":"Shroyer ALW, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, et al. Society of Thoracic Surgeons. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann. Thorac. Surg. 2003;75:1856\u20131864; discussion 1864\u20131865.","DOI":"10.1016\/S0003-4975(03)00179-6"},{"key":"1196_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0195-668X(02)00799-6","volume":"24","author":"F Roques","year":"2003","unstructured":"Roques F. The logistic EuroSCORE. Eur Heart J. 2003;24:882.","journal-title":"Eur Heart J"},{"key":"1196_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/joic.12165","volume":"28","author":"G Schymik","year":"2015","unstructured":"Schymik G, Schr\u00f6fel H, Heimeshoff M, Luik A, Thoenes M, Mandinov L. How to adapt the implantation technique for the new SAPIEN 3 transcatheter heart valve design. J Interv Cardiol. 2015;28:82\u20139.","journal-title":"J Interv Cardiol"},{"key":"1196_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jacc.2007.10.023","volume":"51","author":"R Zegdi","year":"2008","unstructured":"Zegdi R, Ciobotaru V, Noghin M, Sleilaty G, Lafont A, Latr\u00e9mouille C, et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? J Am Coll Cardiol. 2008;51:579\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"1196_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jcin.2018.10.010","volume":"12","author":"R Vera -Urquiza","year":"2019","unstructured":"Vera -Urquiza R, Tirado -Conte G, Armijo G, Jimenez -Quevedo P, Nombela -Franco L. Asymmetric ventricular foreshortening of SAPIEN-3 transcatheter heart valve associated with leaflet subclinical thrombosis. JACC Cardiovasc Interv. 2019;12:100\u20132.","journal-title":"JACC Cardiovasc Interv"},{"key":"1196_CR19","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1093\/eurheartj\/ehz429","volume":"40","author":"W-K Kim","year":"2019","unstructured":"Kim W-K, Sch\u00e4fer U, Tchetche D, Nef H, Arnold M, Avanzas P, et al. Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration). Eur Heart J. 2019;40:3156\u201365.","journal-title":"Eur Heart J"},{"key":"1196_CR20","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1093\/eurheartj\/ehz562","volume":"40","author":"RK Binder","year":"2019","unstructured":"Binder RK, Webb JG. Transcatheter heart valve migration and embolization: rare and preventable? Eur Heart J. 2019;40:3166\u20138.","journal-title":"Eur Heart J"},{"key":"1196_CR21","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.jcin.2024.07.032","volume":"17","author":"J Nuche","year":"2024","unstructured":"Nuche J, Ellenbogen KA, Mittal S, Windecker S, Benavent C, Philippon F, et al. Conduction disturbances after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2024;17:2575\u201395.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-025-01196-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-025-01196-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-025-01196-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:23:31Z","timestamp":1767885811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-025-01196-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1007\/s12928-025-01196-5","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relationships to disclose that are relevant to the contents of this manuscript. Kaoru Dohi received departmental research grant support from Zeon medical Inc., Otsuka Pharmaceutical Co., Ltd, Abbott Medical Japan LLC, and Mochida Pharmaceutical Co., Ltd. Kaoru Dohi also received a speaker fee from Daiichi Sankyo Company Limited, Bayer Yakuhin, Ltd, AstraZeneca PLC, Otsuka Pharmaceutical Co., Nippon Boehringer Ingelheim Co., Novartis Pharma K.K and Abbott Medical Japan LLC. Other authors have no financial conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}